Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Expired

ASH Medical Student Physician-Scientist Award

American Society of Hematology

About ASH

With more than 18,000 members from nearly 100 countries, the ASH is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.

Specialties

Hematology

Genetics & Genomics

Pathology

Eligibility Requirements

At the time of application, the applicant must:

Be an ASH member in good standing or have a membership application pending. To verify your membership status, please log in to your ASH account. Not an ASH member yet? Take the first step. Submit your membership application at least three weeks prior to the application deadline to allow sufficient time for processing.
Be a first-, second-, or third-year medical student actively enrolled in an MD or DO medical program in an LCME or AOA COCA (or its equivalent) accredited medical school in the United States or Canada and be in good standing relative to his/her course work.
Be planning an investigative career in laboratory, translational, or clinical hematology research.
Propose a hematology research project that will be exclusive to the applicant and will be conducted within the mentor’s lab. The project may take place at the institution where the applicant is in medical school or at another institution with sufficient activity in hematology research and education, as judged by the award study section.
Plan to conduct the research at an institution that will allow for continued enrollment in medical school and/or will provide an alternative mechanism for the student to maintain health, dental, and vision insurance during the award term (up to $5,500 in funding is provided for premiums for this insurance).
Agree to spend more than 80 percent of his/her time conducting research during the one-year experience; some clinical shadowing of hematologists or related providers during the year is allowed.
Have a research mentor who is an ASH member in good standing and has active research funding in hematology from the NIH or an equivalent organization. The mentor will assist in completing the program application, oversee the award recipient’s work, aid the recipient in his/her research, and ensure that the recipient meets all deadlines.

The following individuals are not eligible to apply:

Individuals who are currently enrolled in a combined MD-PhD program (students who earned a PhD prior to medical school will be considered on an individual basis if their field of PhD study lies outside of biomedical science)
Individuals who have other concurrent funding for a similar experience

Eligible Countries:

Sponsor Details

Sponsor Institute/Organizations: American Society of Hematology

Sponsor Type:

Address: 2021 L Street NW, Suite 900, Washington, DC 20036

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity